Hostein I, Pelmus M, Aurias A, Pedeutour F, Mathoulin-Pélissier S, Coindre J M
Department of Pathology, Institut Bergonié, Bordeaux, France.
J Pathol. 2004 Jan;202(1):95-102. doi: 10.1002/path.1495.
Atypical lipomatous tumours/well-differentiated liposarcomas and dedifferentiated liposarcomas are characterized by 12q13-15 region amplification. In contrast, this molecular event has not been reported in benign lipomas. Within the 12q13-15 chromosomal region, the MDM2, SAS, HMGA2, and CDK4 genes are the most frequent targets of amplification. A series of lipomas (36 cases) and liposarcomas (48 cases) was analysed for MDM2 and CDK4 gene amplification by real-time PCR. MDM2 and CDK4 gene amplification was detected in 2.8% and 5.6% of lipomas and 98.2% and 82.4% of liposarcomas, respectively. Moreover, co-amplification of the two genes as well as a higher-level amplification was observed more frequently in dedifferentiated liposarcomas than in atypical lipomatous tumours/well-differentiated liposarcomas. Real-time PCR proved to be a fast and reliable method to characterize lipomas and liposarcomas by quantification of MDM2 and CDK4 gene amplification. It is applicable to paraffin wax-embedded tissues and could be useful when histological diagnosis is difficult.
非典型脂肪瘤性肿瘤/高分化脂肪肉瘤和去分化脂肪肉瘤的特征是12q13 - 15区域扩增。相比之下,这种分子事件在良性脂肪瘤中尚未见报道。在12q13 - 15染色体区域内,MDM2、SAS、HMGA2和CDK4基因是最常见的扩增靶点。通过实时PCR对一系列脂肪瘤(36例)和脂肪肉瘤(48例)进行MDM2和CDK4基因扩增分析。MDM2和CDK4基因扩增分别在2.8%的脂肪瘤和5.6%的脂肪肉瘤以及98.2%的脂肪肉瘤和82.4%的脂肪肉瘤中检测到。此外,与非典型脂肪瘤性肿瘤/高分化脂肪肉瘤相比,去分化脂肪肉瘤中更频繁地观察到这两个基因的共扩增以及更高水平的扩增。实时PCR被证明是一种通过定量MDM2和CDK4基因扩增来鉴别脂肪瘤和脂肪肉瘤的快速可靠方法。它适用于石蜡包埋组织,在组织学诊断困难时可能有用。